Skip to Content
Merck
  • Multifunctional mesoporous hollow silica nanocapsules for targeted co-delivery of cisplatin-pemetrexed and MR imaging.

Multifunctional mesoporous hollow silica nanocapsules for targeted co-delivery of cisplatin-pemetrexed and MR imaging.

Dalton transactions (Cambridge, England : 2003) (2014-09-17)
Sasmita Mohapatra, Smruti Ranjan Rout, Rajan Narayan, Tapas K Maiti
ABSTRACT

The development of theranostic mesoporous hollow silica nanospheres having therapeutic and diagnostic functions has been achieved. The exterior surface of the hollow mesoporous silica nanosphere was selectively acid functionalized and utilised to conjugate the anticancer drug cisplatin, the marker molecule folic acid (FA), and rhodamine isothiocyanate (RITC), whereas the interior space was utilised to encapsulate superparamagnetic CoFe2O4 nanoparticles as well as the hydrophobic anticancer drug pemetrexed. The hydrodynamic size of the synthesized multidrug loaded hollow particles is 130 nm in physiological pH and it is consistent over a long period. To the best of our knowledge this is the first report on fluorescent magnetic hollow spheres loaded with multiple therapeutic cargoes as well as a magnetic resonance imaging (MRI) contrast agent. The as prepared hollow spheres are biocompatible. The internalization efficiency of the drug loaded particle has been evaluated on folate receptor overexpressed (FR+ve) HeLa, FR-ve HaCat and 3T3 cells. These drug loaded nanospheres exhibit enhanced cytotoxicity as compared to individual drugs. Such a strategy in the simultaneous administration of pemetrexed and platin drugs may open up opportunities for the treatment of lung cancer at its early stage.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Cobalt(II) acetylacetonate, ≥99.0% (KT)
Supelco
Calcium standard for AAS, analytical standard, 1.000 g/L Ca+2 in hydrochloric acid, traceable to BAM
Sigma-Aldrich
cis-Diamineplatinum(II) dichloride, ≥99.9% trace metals basis
Sigma-Aldrich
Iron(III) acetylacetonate, purum, ≥97.0% (RT)
Sigma-Aldrich
Di-tert-butyl dicarbonate, ≥98.0% (GC)
Sigma-Aldrich
Cobalt(II) acetylacetonate, 97%
Sigma-Aldrich
Iron(III) acetylacetonate, 97%
Sigma-Aldrich
Iron(III) acetylacetonate, ≥99.9% trace metals basis
Sigma-Aldrich
Di-tert-butyl dicarbonate, ReagentPlus®, ≥99%
Sigma-Aldrich
Di-tert-butyl dicarbonate, ReagentPlus®, 99%
Sigma-Aldrich
meso-2,3-Dimercaptosuccinic acid, ~98%
Cisplatin impurity A, European Pharmacopoeia (EP) Reference Standard
Tribenoside impurity D, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Ammonium phosphate dibasic, ACS reagent, ≥98%
Sigma-Aldrich
Ammonium phosphate dibasic, reagent grade, ≥98.0%
Sigma-Aldrich
Ammonium phosphate dibasic, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥98% (alkalimetric)
Oleic acid, European Pharmacopoeia (EP) Reference Standard
SAFC
Hexadecyltrimethylammonium bromide, USP/NF
SAFC
Oleylamine, ≥98% (primary amine)
Supelco
Folic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
(3-Aminopropyl)triethoxysilane, packaged for use in deposition systems, ≥98%
Sigma-Aldrich
Di-tert-butyl dicarbonate solution, 2 M in THF
Sigma-Aldrich
(3-Aminopropyl)triethoxysilane, ≥98.0%
Sigma-Aldrich
(3-Aminopropyl)triethoxysilane, 99%
Folic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Oleylamine, technical grade, 70%
Sigma-Aldrich
Benzyl ether, ≥98%, FCC, FG
Sigma-Aldrich
Oleic acid, natural, FCC
Sigma-Aldrich
Benzyl ether, 98%
Sigma-Aldrich
Oleic acid, technical grade, 90%